ZYDUSLIFEBSEZydus Lifesciences LtdHighNeutral
Announced Fri, 1 May · 13:03 IST

Acquisition of shares of FBC Medical, France

Listed Co AcquisitionStrategic Transactions View source PDF

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.5%1-day move
₹893.00
prior close
₹895.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.5+0.5+0.9+2.5+5.1+5.3+5.3+7.5+5.3+19.9+21.4+28.3
Up moveDown movePending
AI summary

Zydus Lifesciences' wholly-owned subsidiary Amplitude SAS has completed the acquisition of 100% share capital of FBC Medical, France for Euro 700,000 in cash. FBC Medical is a medical equipment distribution company incorporated in 2016, with FY2025 turnover of Euro 935,000. The acquisition aims to internalize commercial capabilities currently outsourced to third-party sales agents, allowing Amplitude to eliminate ongoing commission and business-development fees. The transaction is not a related party transaction and does not require any governmental or regulatory approvals.

Likely market impact

This acquisition is likely positive for shareholders as it verticalizes the distribution chain by bringing sales operations in-house, potentially reducing long-term selling and distribution costs for Amplitude's medical equipment business in France.